Individual Study / Dottorini_J Nucl Med_1995

Dottorini_J Nucl Med_1995

Dottorini_J Nucl Med_1995

Initiatives -
The aim of the present study was to compare the risk in differentiated thyroid carci noma patients treated with I31Iand those not treated with Iodine-131 *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
Start Year
1960
End Year
1993

Members

Download
Investigators Contacts
  • Director Massimo Eugenio Dottorini
    Medicina Nucleare - Azienda Ospedaliera Perugia

Design

Study design
Clinical trial cohort
Follow Up
The mean follow-up was 7.44 years for the patients of Group A and 10.3 years for the patients of Group B.

Marker Paper

Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995 Jan;36(1):21-7.

PUBMED 7799075

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
814
Number of participants with biosamples
Supplementary Information
Females of child-bearing age (patients with thyroid cancer)

Access

Availability of data and biosamples

Data
Biosamples
Other